{
    "mtblsStudy": {
        "studyStatus": "Public",
        "curationRequest": "MANUAL_CURATION",
        "modifiedTime": "2022-11-14T00:00:00",
        "statusUpdateTime": "2022-11-14T14:53:21.458700",
        "read_access": true,
        "write_access": false,
        "is_curator": false
    },
    "isaInvestigation": {
        "comments": [
            {
                "name": "Created With Configuration",
                "value": "MetaboLightsConfig20150707"
            },
            {
                "name": "Last Opened With Configuration",
                "value": "MetaboLightsConfig20150707"
            }
        ],
        "identifier": "MTBLS5155",
        "title": "Investigation",
        "description": "Created using the MetaboLights Online Editor (MOE)",
        "submissionDate": "2022-06-22",
        "publicReleaseDate": "2022-11-14",
        "filename": "",
        "people": [],
        "publications": [],
        "ontologySourceReferences": [
            {
                "comments": [],
                "name": "OBI",
                "file": "http://data.bioontology.org/ontologies/OBI",
                "version": "29",
                "description": "Ontology for Biomedical Investigations"
            },
            {
                "comments": [],
                "name": "CO_340",
                "file": "",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "MTBLS",
                "file": "https://www.ebi.ac.uk/metabolights/",
                "version": "1.0",
                "description": "User defined terms"
            },
            {
                "comments": [],
                "name": "GO",
                "file": "",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "EFO",
                "file": "http://data.bioontology.org/ontologies/EFO",
                "version": "132",
                "description": "Experimental Factor Ontology"
            },
            {
                "comments": [],
                "name": "NCIT",
                "file": "",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "CHMO",
                "file": "",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "SO",
                "file": "",
                "version": "",
                "description": ""
            }
        ],
        "studies": [
            {
                "comments": [],
                "identifier": "MTBLS5155",
                "filename": "s_MTBLS5155.txt",
                "title": "The ULK3 kinase is a key determinant of keratinocyte self-renewal and tumorigenesis targeting the arginine methylome",
                "description": "\nEpigenetic mechanisms oversee epidermal homeostasis and oncogenesis. The identification of kinases controlling these processes has direct therapeutic implications. We show that ULK3 is a nuclear kinase with elevated expression levels in squamous cell carcinomas (SCCs) arising in multiple body sites, including skin and Head/Neck. ULK3 loss by gene silencing or deletion reduces proliferation and clonogenicity of human keratinocytes and SCC-derived cells and affects transcription impinging on stem cell-related and metabolism programs. Mechanistically, ULK3 directly binds and regulates the activity of two histone arginine methyltransferases, PRMT1 and PRMT5 (PRMT1/5), with ULK3 loss compromising PRMT1/5 chromatin association to specific genes and overall methylation of histone H4, a shared target of these enzymes. These findings are of translational significance, as downmodulating ULK3 by RNA interference or locked antisense nucleic acids (LNAs) blunts the proliferation and tumorigenic potential of SCC cells and promotes differentiation in two orthotopic models of skin cancer.\n",
                "submissionDate": "2022-06-22",
                "publicReleaseDate": "2022-11-14",
                "people": [
                    {
                        "comments": [],
                        "firstName": "Sandro",
                        "lastName": "Goruppi",
                        "email": "sgoruppi@mgh.harvard.edu",
                        "affiliation": "CBRC-MGH",
                        "address": "13th Street Charlestown MA",
                        "fax": "",
                        "midInitials": "",
                        "phone": "6177249537",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Investigator",
                                "termSource": {
                                    "comments": [],
                                    "name": "NCIT",
                                    "file": "",
                                    "version": "",
                                    "description": ""
                                },
                                "termAccession": "http://purl.obolibrary.org/obo/NCIT_C25936"
                            }
                        ]
                    },
                    {
                        "comments": [],
                        "firstName": "Andrea",
                        "lastName": "Clocchiatti",
                        "email": "aclocchiatti@mgh.harvard.edu",
                        "affiliation": "CBRC-MGH",
                        "address": "13th Street Charlestown MA",
                        "fax": "",
                        "midInitials": "",
                        "phone": "6177249537",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Investigator",
                                "termSource": {
                                    "comments": [],
                                    "name": "NCIT",
                                    "file": "",
                                    "version": "",
                                    "description": ""
                                },
                                "termAccession": "http://purl.obolibrary.org/obo/NCIT_C25936"
                            }
                        ]
                    },
                    {
                        "comments": [],
                        "firstName": "Giulia",
                        "lastName": "Bottoni",
                        "email": "giuly1632@gmail.com",
                        "affiliation": "CBRC-MGH",
                        "address": "13th Street Charlestown MA",
                        "fax": "",
                        "midInitials": "",
                        "phone": "6177249537",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Investigator",
                                "termSource": {
                                    "comments": [],
                                    "name": "NCIT",
                                    "file": "",
                                    "version": "",
                                    "description": ""
                                },
                                "termAccession": "http://purl.obolibrary.org/obo/NCIT_C25936"
                            }
                        ]
                    },
                    {
                        "comments": [],
                        "firstName": "Dotto",
                        "lastName": "Paolo",
                        "email": "gdotto@partners.org",
                        "affiliation": "CBRC-MGH",
                        "address": "13th Street Charlestown MA",
                        "fax": "",
                        "midInitials": "",
                        "phone": "6177249537",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Investigator",
                                "termSource": {
                                    "comments": [],
                                    "name": "NCIT",
                                    "file": "",
                                    "version": "",
                                    "description": ""
                                },
                                "termAccession": "http://purl.obolibrary.org/obo/NCIT_C25936"
                            }
                        ]
                    }
                ],
                "studyDesignDescriptors": [
                    {
                        "comments": [],
                        "annotationValue": "targeted metabolites",
                        "termSource": {
                            "comments": [],
                            "name": "MTBLS",
                            "file": "https://www.ebi.ac.uk/metabolights/",
                            "version": "1.0",
                            "description": "User defined terms"
                        },
                        "termAccession": "http://www.ebi.ac.uk/metabolights/ontology/MTBLS_000272"
                    },
                    {
                        "comments": [],
                        "annotationValue": "high-performance liquid chromatography-mass spectrometry",
                        "termSource": {
                            "comments": [],
                            "name": "CHMO",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHMO_0000796"
                    },
                    {
                        "comments": [],
                        "annotationValue": "tandem mass spectrometry",
                        "termSource": {
                            "comments": [],
                            "name": "CHMO",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHMO_0000575"
                    },
                    {
                        "comments": [],
                        "annotationValue": "shRNA",
                        "termSource": {
                            "comments": [],
                            "name": "SO",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/SO_0002031"
                    },
                    {
                        "comments": [],
                        "annotationValue": "squamous cell carcinoma",
                        "termSource": {
                            "comments": [],
                            "name": "EFO",
                            "file": "http://data.bioontology.org/ontologies/EFO",
                            "version": "132",
                            "description": "Experimental Factor Ontology"
                        },
                        "termAccession": "http://www.ebi.ac.uk/efo/EFO_0000707"
                    }
                ],
                "publications": [
                    {
                        "comments": [],
                        "title": "The ULK3 kinase is a key determinant of keratinocyte self-renewal and tumorigenesis targeting the arginine methylome",
                        "authorList": "Sandro Goruppi, Andrea Clocchiatti, Giulia Bottoni, Emery Di Cicco, Min Ma, Beatrice Tassone, Victor Neel, Shadhmer Demehri and G. Paolo Dotto",
                        "pubMedID": "",
                        "doi": "",
                        "status": {
                            "comments": [],
                            "annotationValue": "Submitted",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "132",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0001794"
                        }
                    }
                ],
                "factors": [
                    {
                        "comments": [],
                        "factorName": "Kinase ULK3 genotype",
                        "factorType": {
                            "comments": [],
                            "annotationValue": "genotype",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "132",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0000513"
                        }
                    }
                ],
                "protocols": [
                    {
                        "comments": [],
                        "name": "Sample collection",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Sample collection",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Analysis of steady-state metabolites in human squamous cell carcinoma cells (SCC13) infected with 2 separate lentiviruses for ULK3 shRNA, or a silencing control virus, was performed at Beth Israel mass spectrometry core facility. Cells were selected with 1 \u00b5g Puromicin and amplified for 1 week before the experiment.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Extraction",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Extraction",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Briefly, one 10 cm culture dish per condition, in triplicate, was extracted 3x times with 500 \u00b5L 80% cold methanol (-80 \u00b0C). Each extraction was made on ice for 10 min, followed by centrifugation and resuspension of the pellet in 80% methanol, the 3 extractions pooled before next step. Then the extracted metabolites were centrifuged and dried using a speed vacuum concentrator for 30 min with heat. Dried pelleted samples were resuspended in 100 \u00b5L of water before analysis at the Beth Israel Deaconess Mass Spectrometry Core facility directed by Dr. J. Asara<strong>[1]</strong>.</p><p><br></p><p><strong>Ref:</strong></p><p><strong>[1]</strong> Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc. 2012 Apr 12;7(5):872-81. doi:10.1038/nprot.2012.024. PMID:22498707.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Post Extraction",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Derivatization",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Chromatography",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Chromatography",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>The platform uses hydrophilic interaction liquid chromatography with positive/negative ion switching to analyze 258 metabolites (289 Q1/Q3 transitions) from a single 15-min liquid chromatography\u2013mass spectrometry acquisition with a 3-ms dwell time and a 1.55-s duty cycle time<strong>[1]</strong>. The main details were as follows: Prominence HPLC (Shimadzu); Luna NH2 HPLC column (5.0 \u03bcm; 4.6 mm i.d. \u00d7 50 mm length; Phenomenex, cat. no. 00B-4378-E0); Security Guard universal HPLC guard cartridge (Phenomenex, cat. no. AJ0-4301); HPLC buffer A was pH = 9.0: 95% (vol/vol) water, 5% (vol/vol) acetonitrile, 20 mM ammonium hydroxide, 20 mM ammonium acetate, and HPLC B buffer B was 100% acetonitrile; 350-400 \u03bcL/min flow rate and 5-10 \u03bcL injection.</p><p><br></p><p><strong>Ref:</strong></p><p><strong>[1]</strong> Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc. 2012 Apr 12;7(5):872-81. doi:10.1038/nprot.2012.024. PMID:22498707.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Chromatography Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Autosampler model",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Column model",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Column type",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Guard column",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Mass spectrometry",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Mass spectrometry",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>The platform uses hydrophilic interaction liquid chromatography with positive/negative ion switching to analyze 258 metabolites (289 Q1/Q3 transitions) from a single 15-min liquid chromatography-mass spectrometry acquisition with a 3 ms dwell time and a 1.55 s duty cycle time<strong>[1]</strong>. This allowed for up to ~350 unscheduled SRM scans resulting in a sufficient number of scans (approximately 10-12) per metabolite peak in &lt; 2.0 s using a standard HPLC. Chromatographic scheduling of SRM is recommended if duty cycle times are close to ~2.0 s, because an insufficient number of data points will be acquired per metabolite. Relative quantification is achieved without using internal standards, and integrated peak areas based on total ion current can be used for statistical analyses and pathway analyses across biological sample conditions.</p><p><br></p><p><strong>Ref:</strong></p><p><strong>[1]</strong> Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc. 2012 Apr 12;7(5):872-81. doi:10.1038/nprot.2012.024. PMID:22498707.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Scan polarity",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Scan m/z range",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Ion source",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Mass analyzer",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Data transformation",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Data transformation",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Analysis of the raw data (.<strong>wiff.scan</strong>/.<strong>wiff</strong>) was made at the Beth Israel Deaconess Mass Spectrometry Core facility directed by Dr. J. Asara<strong>[1]</strong>. Software for SRM Q1/Q3 peak integration was used, such as <strong>MultiQuant</strong> 2.0 (SCIEX). The metabolites values were evaluated individually for their significance or by 'Metabolite Set Enrichment Analysis' to identify biologically patterns significantly enriched by using <strong>MetaboAnalyst</strong> (<a href='https://www.metaboanalyst.ca/' rel='noopener noreferrer' target='_blank'>https://www.metaboanalyst.ca/</a>).</p><p><br></p><p><strong>Ref:</strong></p><p><strong>[1]</strong> Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc. 2012 Apr 12;7(5):872-81. doi:10.1038/nprot.2012.024. PMID:22498707.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Metabolite identification",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Metabolite identification",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Polar metabolite <strong>KEGG</strong> IDs list representing 258 unique polar metabolites using both negative and positive ion modes along with CEs, chemical formulas, dwell times and database identifiers (<strong>KEGG</strong>, <strong>HMDB</strong> or <strong>PubChem</strong>) for the targeted metabolites<strong>[1]</strong>. Some metabolites are targeted in both positive and negative ion modes as they show response in both ionization modes; however, the chromatography mode used and the pH of HPLC buffers can influence the response in a particular ionization mode.</p><p><br></p><p><strong>Ref:</strong></p><p><strong>[1]</strong> Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc. 2012 Apr 12;7(5):872-81. doi:10.1038/nprot.2012.024. PMID:22498707.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    }
                ],
                "assays": [
                    {
                        "comments": [],
                        "measurementType": {
                            "comments": [],
                            "annotationValue": "metabolite profiling",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "29",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000366"
                        },
                        "technologyType": {
                            "comments": [],
                            "annotationValue": "mass spectrometry",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "29",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000470"
                        },
                        "technologyPlatform": "Liquid Chromatography MS - alternating - hilic",
                        "filename": "a_MTBLS5155_LC-MS_alternating_hilic_metabolite_profiling.txt",
                        "dataFiles": [],
                        "processSequence": [],
                        "sources": [],
                        "samples": [],
                        "otherMaterials": [],
                        "characteristicCategories": [],
                        "units": [],
                        "graph": null
                    }
                ],
                "sources": [],
                "samples": [],
                "processSequence": [],
                "characteristicCategories": [],
                "units": []
            }
        ]
    },
    "validation": {
        "errors": [],
        "warnings": []
    }
}